Latest Schedule 13G passive stakes

FMR LLC and Abigail P. Johnson have updated their Schedule 13G filing, reporting a combined beneficial ownership of 1.4% in Crinetics Pharmaceuticals Inc. common stock as of July 31, 2026.

FMR LLC and Abigail P. Johnson have reported a combined beneficial ownership of 11.6% of Okta Inc.'s Class A Common Stock as of July 31, 2026.

FMR LLC and Abigail P. Johnson have updated their Schedule 13G filing, reporting a combined beneficial ownership of 11.1% in Almony Inds Inc. as of July 31, 2026.

FMR LLC and Abigail P. Johnson have reported beneficial ownership of 14.4% of Neutron Holdings Inc.'s common stock as of July 31, 2026.

FMR LLC, through its subsidiaries, has reported beneficial ownership of 11.8% of Butterfly Network Inc.'s Class A Common Stock as of July 31, 2026.

FMR LLC and Abigail P. Johnson have reported beneficial ownership of 13.3% of Sharplink Inc.'s common stock as of July 31, 2026.

FMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, disclosing beneficial ownership of 10.2% of Waystar Holding Corp's common stock as of July 31, 2026.

FMR LLC and Abigail P. Johnson have reported a combined beneficial ownership of 11.6% in HMH Holding Inc.'s Class A Common Stock as of July 31, 2026.

State Street Corporation has filed a Schedule 13G, reporting beneficial ownership of 11,656,926 shares of Trimble Inc. common stock, representing approximately 5% of the class.

State Street Corporation has filed a Schedule 13G, reporting beneficial ownership of 11,656,926 shares of Trimble Inc. common stock, representing approximately 5% of the class.

State Street Corporation has disclosed beneficial ownership of 4.6% of Travere Therapeutics Inc.'s common stock as of June 30, 2026.

State Street Corporation has disclosed beneficial ownership of 4.6% of Travere Therapeutics Inc.'s common stock as of June 30, 2026.

State Street Corporation has disclosed beneficial ownership of 6.2% of TKO Group Holdings' common stock as of June 30, 2026.

State Street Corporation has disclosed beneficial ownership of 6.2% of TKO Group Holdings' common stock as of June 30, 2026.

State Street Corporation has filed a Schedule 13G, reporting beneficial ownership of 5.5% of Macerich Co. common stock as of June 30, 2026.

State Street Corporation has filed a Schedule 13G, reporting beneficial ownership of 5.5% of Macerich Co. common stock as of June 30, 2026.

State Street Corporation has disclosed beneficial ownership of 5.6% of T1 Energy Inc.'s common stock as of June 30, 2026.

State Street Corporation has disclosed beneficial ownership of 5.6% of T1 Energy Inc.'s common stock as of June 30, 2026.

State Street Corporation has updated its beneficial ownership filing for Syndax Pharmaceuticals Inc., reporting a 6.4% stake as of June 30, 2026.

State Street Corporation has updated its beneficial ownership filing for Syndax Pharmaceuticals Inc., reporting a 6.4% stake as of June 30, 2026.

River Road Asset Management, LLC has amended its Schedule 13G filing to report beneficial ownership of 4.5% of EPLUS INC common stock.

State Street Corporation has disclosed beneficial ownership of 5.4% of Smurfit Westrock PLC's common stock as of June 30, 2026.

State Street Corporation has disclosed beneficial ownership of 5.4% of Smurfit Westrock PLC's common stock as of June 30, 2026.

State Street Corporation has updated its beneficial ownership filing for SM Energy Co., reporting a 4.9% stake as of June 30, 2026.

State Street Corporation has updated its beneficial ownership filing for SM Energy Co., reporting a 4.9% stake as of June 30, 2026.

State Street Corporation has disclosed beneficial ownership of 7% of Sellas Life Sciences Group Inc.'s common stock as of June 30, 2026.

State Street Corporation has disclosed beneficial ownership of 7% of Sellas Life Sciences Group Inc.'s common stock as of June 30, 2026.

State Street Corporation has reported beneficial ownership of 5.5% of Satellogic Inc.'s common stock as of June 30, 2026.

State Street Corporation has reported beneficial ownership of 5.5% of Satellogic Inc.'s common stock as of June 30, 2026.

State Street Corporation and its affiliate SSGA Funds Management, Inc. have filed a Schedule 13G, reporting beneficial ownership of Sarepta Therapeutics Inc. common stock.